Abstract:Targeted delivery of antitumor drugs is especially important for tumor therapy. Cell-penetrating peptides (CPPs) have been shown to be very effective drug carriers for tumor therapy. However, most CPPs lack tumor cell specificity. Here, we identified a highly efficient CPP, CAT, from the newly identified buffalo-derived cathelicidin family, which exhibits a preferential binding capacity for multiple tumor cell lines and delivers carried drug molecules into cells. CAT showed an approximately threefold to sixfold higher translocation efficiency than some reported cell-penetrating antimicrobial peptides, including the well-known classical CPP TAT. Moreover, the delivery efficiency of CAT was greater in a variety of tested tumor cells than in normal cells, especially for the human hepatoma cell line SMMC-7721, for which delivery was 7 times more efficient than the normal human embryonic lung cell line MRC-5, according to fluorescent labeling experiment results. CAT was conjugated to the Momordica charantia-derived type-I ribosome-inactivating protein MAP 30, and the cytotoxicity of the MAP 30-CAT fusion protein in the tumor cell line SMMC-7721 was significantly enhanced compared with that of the unconjugated MAP 30. The IC50 value of MAP 30-CAT was approximately 83 times lower than the IC50 value of the original MAP 30. Interestingly, the IC50 value of MAP 30 alone for MRC-5 was approximately twofold higher than the value for SMMC-7721, showing a small difference. However, when MAP 30 was conjugated to CAT, the difference in IC50 values between the two cell lines was significantly increased by 38-fold. The results of the flow cytometric detection of apoptosis revealed that the increase in cytotoxicity after CAT conjugation was mainly caused by the increased induction of apoptosis by the fusion protein. These results suggest that CAT, as a novel tumor-homing CPP, has great potential in drug delivery applications in vivo and will be beneficial to the development of tumor therapeutics.

The Heparin-Binding Domain of HB-EGF As an Efficient Cell-Penetrating Peptide for Drug Delivery.

Efficient drug delivery by novel cell-penetrating peptide derived from Midkine, with two heparin binding sites braced by a length-specific helix

Structure Optimisation to Improve the Delivery Efficiency and Cell Selectivity of a Tumour-Targeting Cell-Penetrating Peptide

Evaluating the translocation properties of a new nuclear targeted penetrating peptide using two fluorescent markers.

Application of EGF-like Growth Factor-derived Tumor-homing Peptide for Antineoplastic Protein

Enhancing Tumor-Specific Intracellular Delivering Efficiency of Cell-Penetrating Peptide by Fusion with a Peptide Targeting to EGFR

The Use of A Hydrophobic Binding Peptide Modified Lipid Nanocarrier Improving Tumor Distribution and Antitumor Efficacy

Recombinant Expression and Purification of a MAP30-cell Penetrating Peptide Fusion Protein with Higher Anti-Tumor Bioactivity.

Screening and Characterization of a Novel High-Efficiency Tumor-Homing Cell-Penetrating Peptide from the Buffalo Cathelicidin Family.

Engineered Histidine-Rich Peptides Enhance Endosomal Escape for Antibody-Targeted Intracellular Delivery of Functional Proteins

A high hydrophobic moment arginine-rich peptide screened by a machine learning algorithm enhanced ADC antitumor activity

Cell penetrating peptides: Highlighting points in cancer therapy

Gp350-anchored Extracellular Vesicles: Promising Vehicles for Delivering Therapeutic Drugs of B Cell Malignancies

A Modified HLA-A*0201-restricted CTL Epitope from Human Oncoprotein (hpebp4) Induces More Efficient Antitumor Responses

Recent Advances of Cell-Penetrating Peptides and Their Application as Vectors for Delivery of Peptide and Protein-Based Cargo Molecules

[Development of Tumor Targeting PHBHHx Nanoparticles by PhaP Mediated Immobilization of EGFR-targeting Peptide].

Screening and Characterisation of a Novel Efficient Tumour Cell-Targeting Peptide Derived from Insulin-Like Growth Factor Binding Proteins

Charge-guided Masking of a Membrane-Destabilizing Peptide Enables Efficient Endosomal Escape for Targeted Intracellular Delivery of Proteins

An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery

Expression and purification of a recombinant ELRL-MAP30 with dual-targeting anti-tumor bioactivity

Cell-penetrating peptides in cargo delivery : In vitro studies on uptake and in vivo studies on tumor targeting